MedTrace Logo

PRIME vs Usual Care for Clinical High Risk

NCT02960451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-05-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether specialty care is superior to usual care in the treatment of patients at clinical high risk for psychosis.

Conditions

  • Clinical High Risk Syndrome for Psychosis

Interventions

OTHER

PRIME care

Specialist medication, cognitive behavior therapy, family-focused therapy

OTHER

Usual care

Medication and psychotherapy as available form community providers

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Scott Woods, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-05-01
Completion
2019-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02960451 on ClinicalTrials.gov